Comments
Loading...

Exact Sciences Analyst Ratings

EXASNASDAQ
Logo brought to you by Benzinga Data
$51.92
0.751.47%
At close: -
$51.92
0.000.00%
After Hours: 4:03 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$90.00
Lowest Price Target1
$54.00
Consensus Price Target1
$71.88

Exact Sciences Analyst Ratings and Price Targets | NASDAQ:EXAS | Benzinga

Exact Sciences Corp has a consensus price target of $71.88 based on the ratings of 28 analysts. The high is $90 issued by Bernstein on October 30, 2024. The low is $54 issued by RBC Capital on May 2, 2025. The 3 most-recent analyst ratings were released by Barclays, Barclays, and RBC Capital on June 24, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $64.67 between Barclays, Barclays, and RBC Capital, there's an implied 24.55% upside for Exact Sciences Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
3
Apr
3
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
RBC Capital
Evercore ISI Group
Baird
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Exact Sciences

Buy NowGet Alert
06/24/2025Buy Now25.19%Barclays
Luke Sergott53%
$75 → $65MaintainsOverweightGet Alert
05/02/2025Buy Now44.45%Barclays
Luke Sergott53%
$55 → $75MaintainsOverweightGet Alert
05/02/2025Buy Now4.01%RBC Capital
Gerard Cassidy76%
$52 → $54MaintainsSector PerformGet Alert
05/02/2025Buy Now27.12%Evercore ISI Group
Vijay Kumar53%
$60 → $66MaintainsOutperformGet Alert
05/02/2025Buy Now38.67%Baird
Catherine Schulte66%
$69 → $72MaintainsOutperformGet Alert
04/11/2025Buy Now15.56%Guggenheim
Subbu Nambi48%
$60 → $60ReiteratesBuy → BuyGet Alert
04/10/2025Buy Now5.93%Barclays
Luke Sergott53%
$65 → $55MaintainsOverweightGet Alert
04/10/2025Buy Now15.56%Mizuho
Anthony Petrone42%
→ $60Initiates → OutperformGet Alert
03/13/2025Buy Now0.15%RBC Capital
Gerard Cassidy76%
→ $52Initiates → Sector PerformGet Alert
02/26/2025Buy Now34.82%Piper Sandler
David Westenberg62%
$75 → $70MaintainsOverweightGet Alert
02/24/2025Buy Now40.6%Scotiabank
Sung Ji Nam46%
$70 → $73MaintainsSector OutperformGet Alert
02/20/2025Buy Now25.19%B of A Securities
Derik De Bruin86%
$72 → $65MaintainsBuyGet Alert
02/20/2025Buy Now25.19%Barclays
Luke Sergott53%
$70 → $65MaintainsOverweightGet Alert
01/23/2025Buy Now34.82%Barclays
Luke Sergott53%
→ $70Initiates → OverweightGet Alert
01/13/2025Buy Now25.19%Benchmark
Bruce Jackson36%
$65 → $65ReiteratesBuy → BuyGet Alert
12/13/2024Buy Now38.67%B of A Securities
Derik De Bruin86%
$75 → $72MaintainsBuyGet Alert
11/26/2024Buy Now65.64%TD Cowen
Dan Brennan63%
$82 → $86MaintainsBuyGet Alert
11/26/2024Buy Now44.45%BTIG
Mark Massaro69%
$65 → $75MaintainsBuyGet Alert
11/11/2024Buy Now44.45%Piper Sandler
David Westenberg62%
$85 → $75MaintainsOverweightGet Alert
11/06/2024Buy Now44.45%Citigroup
Patrick Donnelly80%
$80 → $75MaintainsBuyGet Alert
11/06/2024Buy Now63.71%Jefferies
Brandon Couillard42%
$84 → $85MaintainsBuyGet Alert
11/06/2024Buy Now25.19%BTIG
Mark Massaro69%
$82 → $65MaintainsBuyGet Alert
11/06/2024Buy Now29.04%Stifel
Daniel Arias79%
$82 → $67MaintainsBuyGet Alert
11/06/2024Buy Now44.45%Canaccord Genuity
Kyle Mikson27%
$95 → $75MaintainsBuyGet Alert
11/06/2024Buy Now57.94%TD Cowen
Dan Brennan63%
$90 → $82MaintainsBuyGet Alert
11/06/2024Buy Now25.19%Goldman Sachs
Matthew Sykes65%
$75 → $65MaintainsBuyGet Alert
11/06/2024Buy Now15.56%Evercore ISI Group
Vijay Kumar53%
$80 → $60MaintainsOutperformGet Alert
11/06/2024Buy Now25.19%Craig-Hallum
Alex Nowark62%
$82 → $65MaintainsBuyGet Alert
11/06/2024Buy Now25.19%Benchmark
Bruce Jackson36%
$67 → $65MaintainsBuyGet Alert
11/06/2024Buy Now29.04%Baird
Catherine Schulte66%
$70 → $67MaintainsOutperformGet Alert
10/30/2024Buy Now73.34%Bernstein
Eve Burstein46%
$75 → $90MaintainsOutperformGet Alert
10/29/2024Buy Now82.97%Canaccord Genuity
Kyle Mikson27%
$75 → $95MaintainsBuyGet Alert
10/01/2024Buy Now54.08%Evercore ISI Group
Vijay Kumar53%
$72 → $80MaintainsOutperformGet Alert
09/26/2024Buy NowRaymond James
Andrew Cooper55%
Reiterates → Market PerformGet Alert
09/13/2024Buy Now44.45%Canaccord Genuity
Kyle Mikson27%
$75 → $75MaintainsBuyGet Alert
09/12/2024Buy Now63.71%Piper Sandler
David Westenberg62%
$75 → $85MaintainsOverweightGet Alert
08/27/2024Buy Now44.45%Wells Fargo
Brandon Couillard42%
→ $75Initiates → OverweightGet Alert
08/01/2024Buy Now29.04%Benchmark
Bruce Jackson36%
$91 → $67MaintainsBuyGet Alert
08/01/2024Buy Now57.94%Stifel
Daniel Arias79%
$100 → $82MaintainsBuyGet Alert
07/17/2024Buy Now44.45%Goldman Sachs
Matthew Sykes65%
$88 → $75MaintainsBuyGet Alert
07/02/2024Buy Now38.67%Evercore ISI Group
Vijay Kumar53%
$80 → $72MaintainsOutperformGet Alert
06/27/2024Buy Now34.82%BTIG
Mark Massaro69%
$80 → $70MaintainsBuyGet Alert
06/27/2024Buy Now34.82%Scotiabank
Sung Ji Nam46%
→ $70Initiates → Sector OutperformGet Alert
06/26/2024Buy Now34.82%BTIG
Mark Massaro69%
$80 → $70MaintainsBuyGet Alert
05/09/2024Buy Now54.08%BTIG
Mark Massaro69%
$85 → $80MaintainsBuyGet Alert
05/09/2024Buy Now63.71%Canaccord Genuity
Kyle Mikson27%
$90 → $85MaintainsBuyGet Alert
05/09/2024Buy Now54.08%Citigroup
Patrick Donnelly80%
$100 → $80MaintainsBuyGet Alert
04/03/2024Buy Now92.6%Citigroup
Patrick Donnelly80%
→ $100MaintainsBuyGet Alert
02/22/2024Buy Now73.34%Canaccord Genuity
Kyle Mikson27%
$100 → $90MaintainsBuyGet Alert
01/02/2024Buy Now75.27%Benchmark
Bruce Jackson36%
→ $91UpgradeHold → BuyGet Alert
12/14/2023Buy Now73.34%Guggenheim
Subbu Nambi48%
→ $90Initiates → BuyGet Alert
12/13/2023Buy NowWolfe Research
Doug Schenkel72%
Initiates → OutperformGet Alert
11/03/2023Buy Now73.34%Goldman Sachs
Matthew Sykes65%
$100 → $90MaintainsBuyGet Alert
10/16/2023Buy Now54.08%Piper Sandler
David Westenberg62%
$90 → $80MaintainsOverweightGet Alert
10/10/2023Buy Now73.34%Piper Sandler
David Westenberg62%
→ $90UpgradeNeutral → OverweightGet Alert
09/28/2023Buy Now59.86%Bernstein
Eve Burstein46%
→ $83Initiates → OutperformGet Alert
08/08/2023Buy Now73.34%Piper Sandler
David Westenberg62%
$80 → $90MaintainsNeutralGet Alert
08/03/2023Buy Now111.86%Jefferies
Brandon Couillard42%
$100 → $110MaintainsBuyGet Alert
08/02/2023Buy Now73.34%Credit Suisse
Dan Leonard60%
$75 → $90MaintainsNeutralGet Alert
08/02/2023Buy Now133.05%Baird
Catherine Schulte66%
$99 → $121MaintainsOutperformGet Alert
08/02/2023Buy NowBenchmark
Bruce Jackson36%
DowngradeBuy → HoldGet Alert
07/24/2023Buy Now111.86%Goldman Sachs
Matthew Sykes65%
$85 → $110MaintainsBuyGet Alert
07/21/2023Buy Now111.86%Goldman Sachs
Matthew Sykes65%
$85 → $110MaintainsBuyGet Alert
06/23/2023Buy Now121.49%Canaccord Genuity
Kyle Mikson27%
$92 → $115MaintainsBuyGet Alert
06/22/2023Buy Now150.39%Citigroup
Patrick Donnelly80%
$100 → $130MaintainsBuyGet Alert
06/22/2023Buy Now84.9%Benchmark
Bruce Jackson36%
→ $96ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now63.71%Stifel
Daniel Arias79%
→ $85ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now77.2%Canaccord Genuity
Kyle Mikson27%
→ $92ReiteratesBuy → BuyGet Alert
06/07/2023Buy Now92.6%Jefferies
Brandon Couillard42%
$82 → $100MaintainsBuyGet Alert
05/11/2023Buy Now92.6%Citigroup
Patrick Donnelly80%
$90 → $100MaintainsBuyGet Alert
05/10/2023Buy Now57.94%Jefferies
Brandon Couillard42%
$72 → $82MaintainsBuyGet Alert
05/10/2023Buy Now69.49%B of A Securities
Derik De Bruin86%
$80 → $88MaintainsBuyGet Alert
05/10/2023Buy Now44.45%Credit Suisse
Dan Leonard60%
$70 → $75MaintainsNeutralGet Alert
05/10/2023Buy Now90.68%Baird
Catherine Schulte66%
$92 → $99MaintainsOutperformGet Alert
05/10/2023Buy Now63.71%Craig-Hallum
Alex Nowark62%
$55 → $85UpgradeHold → BuyGet Alert
05/05/2023Buy Now40.6%UBS
Elizabeth Garcia72%
→ $73Initiates → NeutralGet Alert
03/15/2023Buy Now50.23%Benchmark
Bruce Jackson36%
$54 → $78MaintainsBuyGet Alert
03/09/2023Buy Now73.34%Citigroup
Patrick Donnelly80%
$70 → $90UpgradeNeutral → BuyGet Alert
03/03/2023Buy Now34.82%Piper Sandler
David Westenberg62%
$50 → $70MaintainsNeutralGet Alert
02/22/2023Buy Now46.38%Cowen & Co.
Dan Brennan63%
$56 → $76MaintainsOutperformGet Alert
02/22/2023Buy Now77.2%Baird
Catherine Schulte66%
$89 → $92MaintainsOutperformGet Alert
02/22/2023Buy Now54.08%BTIG
Mark Massaro69%
$85 → $80MaintainsBuyGet Alert
02/22/2023Buy Now44.45%Canaccord Genuity
Kyle Mikson27%
$70 → $75MaintainsBuyGet Alert
02/22/2023Buy Now34.82%Citigroup
Patrick Donnelly80%
$35 → $70MaintainsNeutralGet Alert
02/22/2023Buy Now34.82%Credit Suisse
Dan Leonard60%
→ $70Reiterates → NeutralGet Alert
02/10/2023Buy Now34.82%Credit Suisse
Dan Leonard60%
$50 → $70DowngradeOutperform → NeutralGet Alert
01/18/2023Buy NowRaymond James
Andrew Cooper55%
DowngradeOutperform → Market PerformGet Alert
01/12/2023Buy Now44.45%SVB Leerink
Puneet Souda55%
$70 → $75MaintainsOutperformGet Alert
01/06/2023Buy Now34.82%SVB Leerink
Puneet Souda55%
$60 → $70MaintainsOutperformGet Alert
12/16/2022Buy Now34.82%Jefferies
Brandon Couillard42%
→ $70MaintainsBuyGet Alert
11/14/2022Buy Now-3.7%Piper Sandler
David Westenberg62%
$40 → $50MaintainsNeutralGet Alert
11/08/2022Buy Now15.56%Raymond James
Andrew Cooper55%
$70 → $60MaintainsOutperformGet Alert
11/07/2022Buy Now25.19%BTIG
Mark Massaro69%
$70 → $65MaintainsBuyGet Alert
10/19/2022Buy NowCraig-Hallum
Alexander Nowak53%
DowngradeBuy → HoldGet Alert
08/25/2022Buy Now5.93%Credit Suisse
Dan Leonard60%
→ $55Initiates → OutperformGet Alert
08/17/2022Buy Now-22.96%Piper Sandler
David Westenberg62%
$50 → $40MaintainsOverweightGet Alert
08/03/2022Buy Now15.56%Craig-Hallum
Alex Nowark62%
$81 → $60MaintainsBuyGet Alert
08/03/2022Buy Now29.04%Cowen & Co.
Dan Brennan63%
$83 → $67MaintainsOutperformGet Alert
08/03/2022Buy Now34.82%BTIG
Mark Massaro69%
$100 → $70MaintainsBuyGet Alert
08/03/2022Buy Now44.45%Baird
Catherine Ramsey59%
$90 → $75MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Exact Sciences (EXAS) stock?

A

The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Barclays on June 24, 2025. The analyst firm set a price target for $65.00 expecting EXAS to rise to within 12 months (a possible 25.19% upside). 44 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Exact Sciences (EXAS)?

A

The latest analyst rating for Exact Sciences (NASDAQ:EXAS) was provided by Barclays, and Exact Sciences maintained their overweight rating.

Q

When was the last upgrade for Exact Sciences (EXAS)?

A

The last upgrade for Exact Sciences Corp happened on January 2, 2024 when Benchmark raised their price target to $91. Benchmark previously had a hold for Exact Sciences Corp.

Q

When was the last downgrade for Exact Sciences (EXAS)?

A

The last downgrade for Exact Sciences Corp happened on August 2, 2023 when Benchmark changed their price target from N/A to N/A for Exact Sciences Corp.

Q

When is the next analyst rating going to be posted or updated for Exact Sciences (EXAS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exact Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exact Sciences was filed on June 24, 2025 so you should expect the next rating to be made available sometime around June 24, 2026.

Q

Is the Analyst Rating Exact Sciences (EXAS) correct?

A

While ratings are subjective and will change, the latest Exact Sciences (EXAS) rating was a maintained with a price target of $75.00 to $65.00. The current price Exact Sciences (EXAS) is trading at is $51.92, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch